One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap pharmaceutical stocks totally fit the bill.
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.
Dogs of the Dow is a dividend strategy for investors to buy what are either "cheap" or "beaten up" Dow stocks. Unfortunately, 2015 was an awful year for the members of the…
These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life. They make good sense for conservative portfolios looking for income and growth…
The short interest data have been released for the December 15 settlement date, and for most of the selected pharmaceutical stocks short interest was up.
General Electric saw its short interest drop sharply again between the November 30 and December 15 settlement dates.
December 24, 2015: Markets opened mixed on Thursday after thin trading and little movement in both Europe and Asia. The report on U.S. jobless claims was better than expected, but weakness in…
24/7 Wall St. screened the Jefferies Franchise Picks list for the top-yielding stocks and found four with outstanding growth potential.
December 21, 2015: Markets opened higher on Monday following a changing of the guard at the top of Spain’s government and new hope for another dose of government stimulus in China. A…
At the end of every year, myriad strategies are announced for the coming year. With investors continuing to love dividends, one strategy that is reviewed every year is the so-called Dogs of…
Amgen is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a Big Pharma stock.
Merrill Lynch is among the first firms to present their top picks for 2016, a decidedly conservative set of picks, and probably with good reason.
The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was up.
Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.
With the market very possibly poised for years of sideways trading and single-digit gains, the total return potential from these blue chips is outstanding.
